CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

nedaplatin

Small moleculeexperimental

Nedaplatin is a platinum-based antineoplastic drug which is used for cancer chemotherapy. The complex consists of two ammine ligands and the dianion derived from glycolic acid. — Wikipedia

Clinical trial activity

77 trials · 66 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
67
Phase 3
21
Phase 4
1

Earliest trial started Jul 31, 2001 (NCT00145769)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • DNACROSS-LINKING AGENT

    DNA cross-linking agent

Chemistry & pharmacology

Mol. weight
303.18 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 254-s
  • cdgp
  • cdgp
  • cgdp-ii
  • cis-diammine (glycolato)platinum
  • cis-diammine (glycolato)platinum
  • cis-diammine-glycolatoplatinum
  • cis-diammine(glycolato)platinum
  • cis-diammine(glycolato)platinum
  • cis-diammine(glycolato)platinum ii
  • cis-diammine(glycolato)platinum(ii)
  • cis-diammine(glycolato)platinum(ii)
  • (glycolato-o,o')diammineplatinum ii
  • (glycolato-o,o')diammineplatinum(ii)
  • (glycolato-o,o')diammineplatinum(ii)
  • nadaplatin
  • nadaplatin
  • nedaplatin
  • nedaplatin
  • nedaplatin
  • nedaplatin
  • nsc 375101d
  • nsc-375101d

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07200141Phase 2Oct 1, 2025Chinese Academy of Medical Sciences
NCT07046221Phase 2Aug 1, 2025Fujian Medical University
NCT07019181Phase 2Jul 30, 2025Xiamen University
NCT07086456Phase 2Jul 20, 2025Sun Yat-Sen University
NCT07086469Phase 2Jul 20, 2025Sun Yat-Sen University
NCT06953323Phase 1/Phase 2 (Phase 2)Jul 10, 2025Government of China
NCT07052669Phase 3Jul 1, 2025Sun Yat-Sen University
NCT06912074Phase 2Apr 5, 2025Sun Yat-Sen University
NCT06846450Phase 3Feb 25, 2025Fudan University
NCT07284836Phase 2Feb 1, 2025Chinese Academy of Medical Sciences
NCT06730308Phase 2Nov 20, 2024Sun Yat-Sen University
NCT06508229Phase 2Jul 30, 2024Harbin Medical University
NCT06675214Phase 3Jul 30, 2024Sun Yat-Sen University
NCT06545747Phase 3Jan 1, 2024Sun Yat-Sen University
NCT06092957Phase 3Oct 9, 2023Central South University, Guangzhou Medical University, Huazhong University of Science and Technology, Shantou University, Sun Yat-Sen University, Xiamen University
NCT06010212Phase 1/Phase 2 (Phase 2)Aug 25, 2023Nanjing Medical University
NCT06020885Phase 1Aug 1, 2023Sun Yat-Sen University
NCT06139419Phase 2Jul 25, 2023Sun Yat-Sen University
NCT05860335Phase 2May 31, 2023People's Liberation Army of China
NCT06102395Phase 3May 1, 2023Capital Medical University
Showing 20 of 77 trials
Page 1 / 4

Organizations

Research & Development (66)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Sun Yat-Sen UniversityAcademic/Hospital323242010
Chinese Academy of Medical SciencesAcademic/Hospital131222011
People's Liberation Army of ChinaGovernment9532010
Guangzhou Medical UniversityAcademic/Hospital6232012
Nanjing Medical UniversityAcademic/Hospital6322010
Fujian Medical UniversityAcademic/Hospital4222016
Huazhong University of Science and TechnologyAcademic/Hospital4012014
Capital Medical UniversityAcademic/Hospital3222019
Guangxi Medical UniversityAcademic/Hospital3112011
Guizhou Medical UniversityAcademic/Hospital3122018
Henan Medical UniversityAcademic/Hospital3022016
Peking UniversityAcademic/Hospital3022016
Zhengzhou UniversityAcademic/Hospital3222019
Central South UniversityAcademic/Hospital2012018
First People's Hospital of FoshanAcademic/Hospital2022018
Guangdong Pharmaceutical UniversityAcademic/Hospital2012012
Hacettepe UniversityAcademic/Hospital2122018
Harbin Medical UniversityAcademic/Hospital2122019
Hebei UniversityAcademic/Hospital2022016
Inner Mongolia Medical UniversityAcademic/Hospital2022016
66 organizations
Page 1 / 4